Form 8-K - Current report:
SEC Accession No. 0001641172-25-020877
Filing Date
2025-07-24
Accepted
2025-07-24 17:20:43
Documents
14
Period of Report
2025-07-18
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8-k.htm   iXBRL 8-K 46647
2 EX-99.1 ex99-1.htm EX-99.1 12913
3 GRAPHIC ex99-1_001.jpg GRAPHIC 10893
  Complete submission text file 0001641172-25-020877.txt   248938

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE scnx-20250718.xsd EX-101.SCH 3041
5 XBRL LABEL FILE scnx-20250718_lab.xml EX-101.LAB 34915
6 XBRL PRESENTATION FILE scnx-20250718_pre.xml EX-101.PRE 22806
16 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3742
Mailing Address 20 AUSTIN BLVD. COMMACK NY 11725
Business Address 20 AUSTIN BLVD. COMMACK NY 11725 (800) 261 0281
Scienture Holdings, Inc. (Filer) CIK: 0001382574 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39199 | Film No.: 251147926
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)